Triazavirin
Triazavirin
Triazavirin (pronunciation: /traɪˈæzəˈvɪrɪn/) is an antiviral drug that was developed by the Ural Branch of the Russian Academy of Sciences. It is primarily used for the treatment of influenza and other viral diseases.
Etymology
The name "Triazavirin" is derived from the chemical structure of the drug, which contains three nitrogen atoms (triaza-) and is used as a viral inhibitor (-virin).
Usage
Triazavirin is used in the treatment of various viral diseases, including influenza, hepatitis C, and respiratory syncytial virus. It works by inhibiting the replication of the virus, thereby reducing the severity and duration of the infection.
Related Terms
- Antiviral drug: A type of medication used specifically for treating viral infections.
- Influenza virus: A type of virus that causes influenza.
- Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
- Respiratory syncytial virus: A common virus that causes infections of the lungs and respiratory tract.
See Also
External links
- Medical encyclopedia article on Triazavirin
- Wikipedia's article - Triazavirin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski